Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 3 minute read Pharma Industry News Athira Pharma stock nosedives after Alzheimer’s drug trial results disappoint Athira Pharma’s stock plunged by 75% after the company announced that its Phase 2/3 LIFT-AD clinical trial for… byPallavi MadhirajuSeptember 4, 2024